Cargando…

Direct Medical Expenses and Influencing Factors of MDR/RR-TB in Eastern China: Based on Data from Multi-Hospital Information Systems

BACKGROUND: Multidrug-resistant (MDR) and rifampicin-resistant (RR) tuberculosis (TB) is related to high healthcare costs. However, studies on direct healthcare expenditure in different settings remain inconclusive. Hence, we aimed to examine the direct medical expenses (DME) of patients with MDR/RR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Meng, Peng, Ying, Liu, Kui, Zhou, Lin, Wang, Fei, Chen, Xinyi, Chen, Bin, Hu, Chonggao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518261/ https://www.ncbi.nlm.nih.gov/pubmed/37753096 http://dx.doi.org/10.2147/RMHP.S420082

Ejemplares similares

Diagnosis and Treatment Pathway of MDR/RR-TB in Taizhou, Zhejiang Province, China
por: Lu, Jingting, et al.
Publicado: (2023)

Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012–2020 Period Analysis
por: Lecai, Ji, et al.
Publicado: (2021)

The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature
por: Geiger, Keri, et al.
Publicado: (2021)

Treatment Outcome of MDR/RR TB in a Resource-Constrained Setup: A Four-Year Retrospective Analysis
por: Omer, Abdurahman Abibeker, et al.
Publicado: (2022)

Predictors of sputum culture conversion time among MDR/RR TB patients on treatment in a low-income setting
por: Meshesha, Meiraf Daniel
Publicado: (2022)

Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
por: Soeroto, Arto Yuwono, et al.
Publicado: (2022)

Does optimized adherence support improve treatment outcomes in RR / MDR-TB patients on 18–20 months regimen in Tbilisi, Georgia?
por: Jomidava, Tinatin, et al.
Publicado: (2021)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China
por: Liu, Qiao, et al.
Publicado: (2021)

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
por: Tang, Shenjie, et al.
Publicado: (2013)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

Household catastrophic medical expenses in eastern China: determinants and policy implications
por: Li, Xiaohong, et al.
Publicado: (2013)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
por: Aurin, Tafsina Haque, et al.
Publicado: (2014)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China
por: Zhang, Shao-Jun, et al.
Publicado: (2022)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

High Latent TB Infection Rate and Associated Risk Factors in the Eastern China of Low TB Incidence
por: Chen, Cheng, et al.
Publicado: (2015)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Is hypoglycemia expensive in China?
por: Lan, Kuixu, et al.
Publicado: (2021)

Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010)

The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
por: Mohr-Holland, E., et al.
Publicado: (2021)

RR photons
por: Camara, Pablo G., et al.
Publicado: (2011)

Why has MDR-TB prevalence increased in Iran?
por: Heidary, Mohsen, et al.
Publicado: (2016)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

759. Molecular Characterization and Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis (MDR-TB) and Identification of Possible Cases of Local Transmission of MDR-TB in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2018)

Impacts of unifying urban and rural residents’ medical insurance on the hospitalisation expenses of rural patients in eastern China: an interrupted time series analysis
por: Qin, Zhaohui, et al.
Publicado: (2023)

Correction: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

The role of bacteriological monitoring using culture and drug susceptibility tests (CDST) on treatment outcomes among MDR/RR-TB patients on treatment: a cohort analysis of patients enrolled on treatment 2010-2015 in Zimbabwe
por: Matambo, Ronnie, et al.
Publicado: (2021)

Mass Tuberculosis Screening Among the Elderly: A Population-Based Study in a Well-Confined, Rural County in Eastern China
por: Hu, Zhengfang, et al.
Publicado: (2023)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China
por: Liu, Y., et al.
Publicado: (2021)

Shielding Studies for RR13/17 and RR53/57 Areas
por: Kwee, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d8elsovsrbik5lemj0bancvirq